Deal Announcements

Cerulean Pharma Raises Fourth Venture Capital Round

Friday, December 16, 2011 5:32:00 AM PDT | VentureDeal Staff

   Cambridge, Massachusetts  --  Cerulean Pharma has garnered $15 million in its series D round of institutional venture capital financing.

Cerulean is developing nanobiology-based approaches to make drugs more effective and with fewer side effects.

Investors in the round included Bessemer Venture Partners, Polaris Venture Partners, Venrock, Lilly Ventures, Lux Capital and CVF.

The company said it would use the financing to continue trials of its CRLX101 candidate.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1